NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/07/2025
Back to search
Official data from USPTO
BIOLOGY TO BARCODES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOLOGY TO BARCODES
ST13
US500000090364536Class
5, 10, 44
Filing
90364536
Registration
7644688
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
01/07/2025
Trademark type
Word
Nice classes
5, 10, 44
Filing date
12/07/2020
Registration date
01/07/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/07/2025
Last transaction
01/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/30/2021
First use in commerce
03/30/2021
Drawing code
4
Owner type
03
Owner location
Carlsbad, CA
Examiner
GOODWIN, KATRINA JOYE
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BioSpyder Technologies, Inc.
Representatives
Leigh AUGUSTINE EIP US LLP
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical reagents for medical or veterinary purposes; Clinical medical reagents; Diagnostic agentspreparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncancerinherited diseasesinfectious diseaseviral diseaseCovid-19influenzarespiratory syncytial viruscoronary artery disease riskschizophrenia risk; Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for veterinary purposes; Diagnostic reagents for medicinal use; Enzyme preparations for medical purposes; Enzyme preparations for veterinary purposes; Enzymes for medical purposes; Enzymes for veterinary purposes; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic test strips for use in the field of cancerinherited diseasesinfectious diseaseviral diseaseCovid-19influenzarespiratory syncytial viruscoronary artery disease riskschizophrenia risk; Medical diagnostic test strips for blood analysisurine analysissaliva analysiswater analysisliquid biopsy; Nucleic acid sequences and chemical reagents for medical and veterinary purposes
Class 10
Blood collection kit comprised of blood collection bagholder for medical sample tubes and vialsmedical sample tubes and vials; Blood component separation apparatus for medical purposes; Blood containers for medical purposes; Blood filters; Blood testing apparatusblood collecting tubes; Blood testing apparatusblood sampling tubes; Filters for blood and blood components for medical purposes; Medical apparatus and instrument for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; Medical apparatus for detecting cancer; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for diagnosing or treating respiratory conditionscancerinherited diseasesinfectious diseaseviral diseaseCovid-19influenzarespiratory syncytial viruscoronary artery disease riskschizophrenia risk; Medical device and surgical instrument for use in diagnosis and surgery of the gastro-intestinal tract; Medical device for detecting cancer; Medical devices for dosimetry purposes in the field of radiotherapy; Medical devices for use in treating or diagnosing cancerinherited diseasesinfectious diseaseviral diseaseCovid-19influenzarespiratory syncytial viruscoronary artery disease riskschizophrenia risk; Medical devices for use in treating or diagnosing cancerinherited diseasesinfectious diseaseviral diseaseCovid-19influenzarespiratory syncytial viruscoronary artery disease riskschizophrenia risk with integrated recorded operating system softwaresold as a unit; Medical devices for use in treating or diagnosing cancerinherited diseasesinfectious diseaseviral diseaseCovid-19influenzarespiratory syncytial viruscoronary artery disease riskschizophrenia risk with integrated recorded software for detecting labeled molecules and analyzing genetic dataaligning sequencescontrolling laboratory equipmentbioinformaticsexpression profilingmetabolic pathwayssold as a unit; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing for viruses; Medical diagnostic apparatus for testing the presence of nucleic acids and antigensmodifications thereofgene expressiontissue structuresradiation exposure; Medical diagnostic apparatus for testing biological samplesDNARNAproteinsvirusessingle cellstissueorgansbiochemical preparationswaste water incorporating recorded operating system software; Medical diagnostic instruments for the analysis of body fluids; Medical instruments for analysing and identifying bacteria; Medical instruments for analyzing and identifying bacteria; Medical instruments for use in treating cancerinherited diseasesinfectious diseaseviral diseaseCovid-19influenzarespiratory syncytial viruscoronary artery disease riskschizophrenia risk; Medical instrumentsbiosensors for detecting infectious diseases; Medical specimen collection devices in the nature of bottlestubesswabssyringeswipes for the collection of nasal mucusrespiratory dropletssalivabloodurinefeces; Sample preparation device for medical diagnostic uses
Class 44
DNA screening for medical purposes; Genetic testing for medical purposes; Genetic testing of animals for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for the diagnosis of cancer; Medical diagnosis and treatment of cancerinherited diseasesinfectious diseaseviral diseaseCovid-19influenzarespiratory syncytial viruscoronary artery disease riskschizophrenia risk; Medical diagnosis of cancerinherited diseasesinfectious diseaseviral diseaseCovid-19influenzarespiratory syncytial viruscoronary artery disease riskschizophrenia risk; Medical diagnostic testingmonitoring and reporting services; Medical dosimetry services for treating radiation exposure; Medical screening; Medical screening services in the field of cancerinherited diseasesinfectious diseaseviral diseaseCovid-19influenzarespiratory syncytial viruscoronary artery disease riskschizophrenia risk; Medical services; Medical testing for diagnostic or treatment purposes; Medical testing of urinebloodhair follicles and breath; Providing cancer screening services; Providing information in the field of cancer preventionscreeningdiagnosis and treatment; Providing information in the field of diabetes; Veterinary specialty services providing advanced medicaldiagnostic or surgical services for animals
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/07/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/18/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/10/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/10/2024
ALIE
ASSIGNED TO LIE
12/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/31/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/31/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/01/2024
GNRT
NON-FINAL ACTION E-MAILED
08/01/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
08/01/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/15/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/14/2024
IUAF
USE AMENDMENT FILED
01/24/2024
EISU
TEAS STATEMENT OF USE RECEIVED
01/24/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/05/2023
EX4G
SOU EXTENSION 4 GRANTED
08/03/2023
EXT4
SOU EXTENSION 4 FILED
08/03/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/03/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/02/2023
EX3G
SOU EXTENSION 3 GRANTED
01/31/2023
EXT3
SOU EXTENSION 3 FILED
01/31/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/31/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/02/2022
EX2G
SOU EXTENSION 2 GRANTED
07/29/2022
EXT2
SOU EXTENSION 2 FILED
07/29/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/29/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/05/2022
EX1G
SOU EXTENSION 1 GRANTED
02/03/2022
EXT1
SOU EXTENSION 1 FILED
02/03/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/03/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/13/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/13/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/13/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2021
PUBO
PUBLISHED FOR OPPOSITION
06/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/19/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/03/2021
DOCK
ASSIGNED TO EXAMINER
04/26/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2021
NWAP
NEW APPLICATION ENTERED
12/10/2020
Continuous trademark protection
Get notified about every new filing that threatens BIOLOGY TO BARCODES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.